Bactiguard Holding AB (OSTO:BACTI B)
kr 67.8 -1.2 (-1.74%) Market Cap: 2.38 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 6.92 GF Score: 73/100

Q3 2022 Bactiguard Holding AB Earnings Call Transcript

Oct 27, 2022 / 09:00AM GMT
Release Date Price: kr103.4 (-1.34%)
Anders GÃ;ransson
Bactiguard Holding AB - CEO

¶ -

Thank you, operator, and welcome to all our shareholders, investors, analysts, and all others joining today's call. Today, we will share our Q3 results, which shows continued strong revenue growth as well as positive EBITDA even in light of the investments we're doing to set us up to execute on our long-term financial targets. We'll also spend time on our ongoing licensing projects, which are giving us a good momentum.

If we go to page 2 and before we go into the financials, I just want to reiterate why Bactiguard's vision is so important. It is not surprising that demand for our products is increasing, considering the benefits that infection prevention can provide both for individuals and society at large.

Avoiding an infection, for example, in connection with orthopedic surgery or extended use of a urinary catheter or venous catheter could mean the difference between life and death. This has never been more important than right now, when we have a significant care gap after the pandemic, which creates a pressure on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot